College of Pharmacy
In this section
Podcast Archive
In this section
HelixTalk #163 - The Two-Drug Tango: A Concise Guide to Tacrolimus and Mycophenolate in Organ Transplantation
Date posted: April 4, 2023, 6:00 am
In this episode, we review clinical pearls and common pitfalls of immunosuppression regimens for organ transplantation with a particular focus on tacrolimus and mycophenolate.
HelixTalk 162 - A1C You Later: A Concise Review of Continuous Glucose Monitors for the Practicing Pharmacist
Date posted: March 14, 2023, 6:00 am
In this first ever CE episode, we discuss the A-Zs of continuous glucose monitors (CGMs).
ACPE-Accredited Pharmacist CE (1.0 hrs)
To obtain CE credit for a $5 fee, visit the following link: https://rfums.wufoo.com/forms/z1qzh5vf0ggr832/. Once payment is successful, you will be redirected to our CE partner (CE Impact) to complete an evaluation and to earn 1.0 hour of CE credit. CE is available for 12 months after episode publication.
HelixTalk #161 - My Loss Is Your Gain! How Drug Repository Programs Are Helping Patients Afford High-cost Medications
Date posted: February 21, 2023, 6:00 am
In this episode, we interview Dr. Shannon Rotolo and Dr. Alex Berce regarding Illinois and Wisconsin drug repository programs – these are programs that allow certain medications to be donated to participating sites and then redistributed to patients at a very low dispensing cost.
HelixTalk #160 - Dextromethorphan for Depression? Analyzing Data for Auvelity® in Major Depressive Disorder
Date posted: January 31, 2023, 6:00 am
In this episode, we discuss the evidence, safety, and place in therapy of Auvelity® (dextromethorphan-bupropion), a newly approved antidepressant with a unique mechanism of action and interesting pharmacokinetic considerations.
HelixTalk #159 - A Breath of Fresh Air: Big Changes to the 2023 GOLD Guidelines for COPD
Date posted: January 10, 2023, 6:00 am
In this episode, we highlight important changes to the 2023 GOLD Guidelines for COPD. In particular, we discuss a revision to the GOLD group classification system and the preferred initial therapies in patients with COPD.
HelixTalk #158 - PADing Your Understanding of Peripheral Arterial Disease: A Brief Treatment Overview
Date posted: December 21, 2022, 6:00 am
In this episode, we will discuss all things peripheral arterial disease – definitions, staging, clinical presentation, risk factors, goals of therapy, and guideline-directed medication therapy recommendations including the newest evidence for the use of DOACs.
HelixTalk #157 - Everything Will Be ao-K+: Potassium Formulations and Dosing for Hypokalemia
Date posted: November 29, 2022, 6:00 am
In this episode, we review the management of a patient with hypokalemia, including both inpatient and outpatient supplementation with potassium chloride supplements and what dosage forms are available for potassium repletion.
HelixTalk #156 - There Is an App for That: Digital Health Advancements and More!
Date posted: November 8, 2022, 6:00 am
In this episode, we will define Digital Health, its categories and examples, describe how pharmacists are involved in DH practice, opportunities and limitations and future of DH. We will also discuss what implications DH has for educators, educational institutions, student pharmacists, pharmacists, and practice of pharmacy in general.
HelixTalk #155 - Oncology 911: Tumor Lysis Syndrome as an Oncologic Emergency
Date posted: October 18, 2022, 6:00 am
In this episode, we invite Dr. Amir Ali, PharmD, BCOP to discuss with us the pathophysiology, risk factors, prevention, and treatment clinical pearls of tumor lysis syndrome TLS).
HelixTalk #154 - What’s New With Paxlovid: Drug Interactions, Pharmacist Prescribing, “Paxlovid Mouth”, and a Brief Drug Review
Date posted: September 27, 2022, 6:00 am
In this episode, we review Paxlovid (nirmatrelvir/ritonavir) from the perspective of its pharmacology, efficacy, safety, pharmacists’ authority to prescribe, drug interactions, and rebound symptoms after Paxlovid therapy.